Education
About Us
Working with TipRanks
Follow Us
60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ:SXTP
RESEARCH TOOLSreports
Total Valuation
60 Degrees Pharmaceuticals, Inc. has a market cap or net worth of $4.65M. The enterprise value is $7.69M.
Market Cap$4.65M
Enterprise Value$7.69M
Share Statistics
60 Degrees Pharmaceuticals, Inc. has 1,472,891 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,472,891
Owned by Insiders19.49%
Owned by Institutions1.36%
Financial Efficiency
60 Degrees Pharmaceuticals, Inc.’s return on equity (ROE) is -2.01 and return on invested capital (ROIC) is -236.83%.
Return on Equity (ROE)-2.01
Return on Assets (ROA)-1.38
Return on Invested Capital (ROIC)-236.83%
Return on Capital Employed (ROCE)-2.37
Revenue Per Employee202.52K
Profits Per Employee0.00
Employee Count3
Asset Turnover0.11
Inventory Turnover0.87
Valuation Ratios
The current PE Ratio of 60 Degrees Pharmaceuticals, Inc. is -0.37. 60 Degrees Pharmaceuticals, Inc.’s PEG ratio is >-0.01.
PE Ratio-0.37
PS Ratio6.92
PB Ratio0.74
Price to Fair Value0.74
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio>-0.01
Income Statement
In the last 12 months, 60 Degrees Pharmaceuticals, Inc. had revenue of 607.57K and earned -7.96M in profits. Earnings per share was -17.50.
Revenue607.57K
Gross Profit222.81K
Operating Income-9.71M
Pretax Income-7.96M
Net Income-7.96M
EBITDA-9.71M
Earnings Per Share (EPS)-17.50
Cash Flow
In the last 12 months, operating cash flow was -4.07M and capital expenditures -245.58K, giving a free cash flow of -4.32M billion.
Operating Cash Flow-4.07M
Free Cash Flow-4.32M
Free Cash Flow per Share-2.93
Dividends & Yields
60 Degrees Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.51
52-Week Price Change-82.25%
50-Day Moving Average2.24
200-Day Moving Average5.68
Relative Strength Index (RSI)63.15
Average Volume (3m)3.10M
Important Dates
60 Degrees Pharmaceuticals, Inc. upcoming earnings date is Nov 14, 2024, TBA Not Confirmed.
Last Earnings DateAug 14, 2024
Next Earnings DateNov 14, 2024
Ex-Dividend Date―
Financial Position
60 Degrees Pharmaceuticals, Inc. as a current ratio of 3.25, with Debt / Equity ratio of 2.59%
Current Ratio3.25
Quick Ratio2.98
Debt to Market Cap0.00
Net Debt to EBITDA0.17
Interest Coverage Ratio1.23K
Taxes
In the past 12 months, 60 Degrees Pharmaceuticals, Inc. has paid 250.00 in taxes.
Income Tax250.00
Effective Tax Rate>-0.01
Enterprise Valuation
60 Degrees Pharmaceuticals, Inc. EV to EBITDA ratio is -0.13, with an EV/FCF ratio of 0.00.
EV to Sales2.09
EV to EBITDA-0.13
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
60 Degrees Pharmaceuticals, Inc. has $5.01M in cash and marketable securities with $18.80M in debt, giving a net cash position of -$4.86M billion.
Cash & Marketable Securities$5.01M
Total Debt$18.80M
Net Cash-$4.86M
Net Cash Per Share-$3.30
Tangible Book Value Per Share$12.00
Margins
Gross margin is 8.19%, with operating margin of -1598.97%, and net profit margin of -1309.41%.
Gross Margin8.19%
Operating Margin-1598.97%
Pretax Margin-1309.37%
Net Profit Margin-1309.41%
EBITDA Margin-1598.97%
EBIT Margin-1310.68%
Analyst Forecast
The average price target for 60 Degrees Pharmaceuticals, Inc. is $3.40, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$3.40
Price Target Upside7.59% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast168.70%
EPS Growth Forecast31.57%